Search Results - B Charpentier

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study

    Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study by Nassim Kamar, Valérie Garrigue, A. Karras, G. Mourad, N Lefrançois, B Charpentier, Christophe Legendre, Lionel Rostaing

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS

    BENEFIT-RISK PROFILE OF THE BELATACEPT LI REGIMEN AT 2 YEARS IN EBV(+) KIDNEY TRANSPLANT RECIPIENTS by F. Vincenti, J. Grinyó, Christian P. Larsen, José Osmar Medina Pestana, Yves Vanrenterghem, Tao Duan, Mamta Agarwal, B Charpentier

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT)

    OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT) by F. Vincenti, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Lionel Rostaing, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Christian P. Larsen

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY

    BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY by Christian P. Larsen, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Nassim Kamar, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Pushkal Garg, F. Vincenti

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

    FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia by Maurizio Salvadori, Klemens Budde, B Charpentier, Jürgen Klempnauer, Björn Nashan, Luis Pallardó, Josette Eris, Francesco Paolo Schena, Ute Eisenberger, Lionel Rostaing, Abdel Hmissi, Shreeram Aradhye

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteers

    Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents a... by A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, S. De Jonge, A. Vardy, B Charpentier, J. Noury, W.C.A. van Beek, Rowie Borst, Gerard J. Ligthart, G. Keren, Eitan Rubinstein

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials

    Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials by Bernhard K. Krämer, Luisa Albano, Bernhard Banas, B Charpentier, Lars Bäckman, Hélio Tedesco‐Silva, Frank Lehner, G. Mondragon-Ramirez, Maciej Głyda, E. Cassuto‐Viguier, Ondřej Viklický, G. Mourad, Paolo Rigotti, S Schleibner, Nassim Kamar

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

    Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study by Rachel Hellemans, Marc Hazzan, D. Durand, G. Mourad, P Lang, Martin Kessler, B Charpentier, Guy Touchard, F. Berthoux, Pierre Merville, Nacéra Ouali, J.P. Squifflet, François Bayle, Karl Martin Wissing, C. Noël, Daniel Abramowicz

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

    Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients by Flavio Vincenti, Christian P. Larsen, Josefina Alberú, Barbara A. Bresnahan, Valter Duro Garcı́a, J. Kothari, Philippe Lang, Eduardo Mancilla Urrea, P. Massari, G. Mondragon-Ramirez, Rafael Reyes‐Acevedo, Kim Rice, Lionel Rostaing, S. Steinberg, J. Xing, Mamta Agarwal, M. Harler, B Charpentier

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study

    Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Rand... by Philippe Gatault, Nassim Kamar, M. Büchler, Claudio Colosio, Dominique Bertrand, Antoine Dürrbach, Laetitia Albano, J Rivalan, Yannick Le Meur, Marie Essig, Nicolas Bouvier, Christophe Legendre, Bruno Moulin, A.E. Heng, P.-F. Weestel, Johnny Sayegh, B Charpentier, Lionel Rostaing, Éric Thervet, Yvon Lebranchu

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice

    Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice by Paula M. Chilton, Smita Ghare, B Charpentier, S Myers, Aakarsha V. Rao, Joseph F. Petrosino, Kristi L. Hoffman, John C. Greenwell, Neetu Tyagi, Jyotirmaya Behera, Yali Wang, Lucy Sloan, JingWen Zhang, Christopher Shields, Gregory E. Cooper, Leila Gobejishvili, Scott R. Whittemore, Craig J. McClain, Shirish Barve

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: